These findings highlight the potential of ACKR3 in lipid metabolism and suggest that ACKR3 may be a possible contributor to metabolic diseases, such as insulin resistance, obesity, and atherosclerosis, which remains to be validated in future studies. This evidence concerns the gene ACKR3 and atherosclerosis.